Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia

Published:2017-06-05 Issue:9 Volume:92 Page:858-865
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Aldoss Ibrahim¹,Song Joo²,Stiller Tracey³,Nguyen Tina⁴,Palmer Joycelynne³,O'Donnell Margaret¹,Stein Anthony S.¹,Marcucci Guido¹,Forman Stephen¹,Pullarkat Vinod¹^ORCID

Affiliation:

1. Department of Hematology and Hematopoietic Cell Transplantation; Gehr Family Center for Leukemia Research, City of Hope Medical Center; Duarte California

2. Department of Information Sciences, Division of Biostatistics; City of Hope Medical Center; Duarte California

3. Department of Pathology; City of Hope Medical Center; Duarte California

4. Department of Pharmacy; City of Hope Medical Center; Duarte California

Publisher

Wiley

Subject

Hematology

Reference19 articles.

1. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study;Topp;Lancet Oncol.,2015

2. Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia;Topp;JCO.,2014

3. Immunotherapy delivered by Blinatumomab improves survival in acute lymphoblastic leukaemia patients;Topp;Haematologica.,2016

4. Pharmacokinetics/pharmacodynamics (PKPD) of blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL);Zhu;J Clin Oncol.,2015

5. Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab;Klinger;Blood.,2012

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral Spinal Fluid Parameters Following CD19-Targeted Therapies in Children and Young Adults;Journal of Pediatric Hematology/Oncology;2023-10-09

2. Optimizing CAR‐T cell therapy in adults with B‐cell acute lymphoblastic leukemia;European Journal of Haematology;2023-09-29

3. Immunotherapy in hematologic malignancies: achievements, challenges and future prospects;Signal Transduction and Targeted Therapy;2023-08-18

4. Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children;Frontiers in Pediatrics;2023-08-04

5. Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review;Leukemia & Lymphoma;2023-08